avatar for David Slack, MBA

David Slack, MBA

Chief Business Officer
David has a track record of innovation in business development, fundraising and in senior management positions at public and private biotech as well as large pharmaceutical companies. His deal-making experience encompasses well over $1 billion in corporate partnerships, spin-outs, startup and financings. David co-founded and serves as CBO at Viracta, an innovative drug development company focused on novel treatments for virus-associated cancers. Prior to Viracta, David served as head of corporate development and strategy for Novimmune, a next generation antibody company. Previously, David served as Vice President for Business Development at Ionis (then Isis) Pharmaceuticals, where he was responsible for several major partnerships and establishment of “satellite companies.” From the “buy side” corporate partnering perspective, David served in senior licensing positions as Rhône-Poulenc Rorer, RPR Gencell and Aventis Pharmaceuticals, where he was responsible for multiple major strategic partnerships.